NEULANDLAB

Neuland Laboratories Share PriceNeuland Laboratories

₹5,126.7
-186.05 (-3.5%)
As on 06 December, 2023 | 03:24 BSE: 524558 NSE: NEULANDLABISIN: INE794A01010

Neuland Laboratories Performance

Day Range

  • Low 5,109.00
  • High 5,329.90
₹ 5,126.7

52 Week Range

  • Low 1,318.10
  • High 5,601.40
₹ 5,126.7
  • Open Price5,325.00
  • Previous Close5,312.75
  • Volume65142

Start SIP in Neuland Laboratories

Start SIP

Neuland Laboratories Share Price

  • Over 1 Month 32.59%
  • Over 3 Month 37.27%
  • Over 6 Month 81.78%
  • Over 1 Year 200.4%

Neuland Laboratories Key Statistics

P/E Ratio 24.7
PEG Ratio 0.1
Market Cap Cr 6,578
Price to Book Ratio 6.7
EPS 127.7
Dividend 0.2
Relative Strength Index 56.47
Money Flow Index 62.86
MACD Signal 306.09
Average True Range 239.26

Neuland Laboratories Investment Rating

  • Master Rating:
  • Neuland Laboratories has an operating revenue of Rs. 1,457.07 Cr. on a trailing 12-month basis. An annual revenue growth of 26% is outstanding, Pre-tax margin of 18% is great, ROE of 16% is good. The company has a reasonable debt to equity of 7%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 21% and 70% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 26% from the pivot point (which is extended from the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 99 which is a GREAT score indicating consistency in earnings, a RS Rating of 94 which is GREAT indicating the outperformance as compared to other stocks, Buyer Demand at A which is evident from recent demand for the stock, Group Rank of 75 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of A is the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has great fundamentals and technical strength to stay in momentum.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Neuland Laboratories Financials
IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 418363407269294221256
Operating Expenses Qtr Cr 280266287215225193217
Operating Profit Qtr Cr 1379712054692839
Depreciation Qtr Cr 15141313131312
Interest Qtr Cr 4243333
Tax Qtr Cr 32212681532
Net Profit Qtr Cr 89628530381022
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 1,201953
Operating Expenses Annual Cr 920809
Operating Profit Annual in Cr 271142
Depreciation Cr 5349
Interest Annual Cr 1313
Tax Annual Cr 5218
Net Profit Annual Cr 16364
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 23959
Cash from Investing Activity Annual Cr -61-94
Cash from Financing Annual Activity Cr -13638
Net Cash Flow Annual Cr 413
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 988836
Fixed Assets Annual Cr 798788
Total Non Current Assets Annual Cr 819801
Total Current Assets Annual Cr 760581
Total Assets Annual Cr 1,5791,382
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 766648
ROE Annual % 178
ROCE Annual % 209
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 2415
IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 418363407269294221256
Operating Expenses Qtr Cr 280266287215224193217
Operating Profit Qtr Cr 1379712054692939
Depreciation Qtr Cr 15141313131312
Interest Qtr Cr 4243333
Tax Qtr Cr 32212681532
Net Profit Qtr Cr 89628531381022
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 1,201953
Operating Expenses Annual Cr 919808
Operating Profit Annual in Cr 272143
Depreciation Cr 5349
Interest Annual Cr 1313
Tax Annual Cr 5218
Net Profit Annual Cr 16464
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 23759
Cash from Investing Activity Annual Cr -61-94
Cash from Financing Annual Activity Cr -13638
Net Cash Flow Annual Cr 403
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 994841
Fixed Assets Annual Cr 519508
Total Non Current Assets Annual Cr 819801
Total Current Assets Annual Cr 761583
Total Assets Annual Cr 1,5801,383
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 771652
ROE Annual % 168
ROCE Annual % 209
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 2415

Neuland Laboratories Technicals

EMA & SMA

Current Price
₹5,126.7
-186.05 (-3.5%)
pointer
  • Bullish Moving Average
  • ___
  • 10
  • Bearish Moving Average
  • ___
  • 6
  • 20 Day
  • ₹5,066.16
  • 50 Day
  • ₹4,584.07
  • 100 Day
  • ₹4,074.98
  • 200 Day
  • ₹3,401.06
  • 20 Day
  • ₹5,226.80
  • 50 Day
  • ₹4,407.78
  • 100 Day
  • ₹4,015.01
  • 200 Day
  • ₹3,142.63

Neuland Laboratories Resistance and Support

PIVOT
₹5,188.54
Resistance
First Resistance 5,268.07
Second Resistance 5,409.43
Third Resistance 5,488.97
RSI 56.47
MFI 62.86
MACD Single Line 306.09
MACD 258.15
Support
First Resistance 5,047.17
Second Resistance 4,967.63
Third Resistance 4,826.27

Neuland Laboratories Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 70,152 5,469,050 77.96
Week 51,555 3,714,538 72.05
1 Month 70,210 3,139,106 44.71
6 Month 49,653 2,533,307 51.02

Neuland Laboratories Result Highlights

Neuland Laboratories Synopsis

NSE-Medical-Diversified

Neuland Laborat is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 1191.20 Cr. and Equity Capital is Rs. 12.90 Cr. for the Year ended 31/03/2023. Neuland Laboratories Ltd. is a Public Limited Listed company incorporated on 07/01/1984 and has its registered office in the State of Telangana, India. Company’s Corporate Identification Number(CIN) is L85195TG1984PLC004393 and registration number is 004393.
Market Cap 6,578
Sales 1,457
Shares in Float 0.82
No of funds 116
Yield 0.19
Book Value 6.7
U/D Vol ratio 2
LTDebt / Equity 8
Alpha 0.47
Beta 1.22

Neuland Laboratories

Owner NameSep-23Jun-23Mar-23Dec-22
Promoters 35.97%36.03%36.14%36.14%
Mutual Funds 1.94%1.57%0.99%0.79%
Foreign Portfolio Investors 21.57%20.19%18.14%17.7%
Individual Investors 27.86%29.01%29.85%30.09%
Others 12.66%13.2%14.88%15.28%

Neuland Laboratories Management

Name Designation
Dr. Davuluri Rama Mohan Rao Executive Chairman
Mr. Davuluri Sucheth Rao Vice Chairman & CEO
Mr. Davuluri Saharsh Rao Vice Chairman & Mng.Director
Dr. Christopher M Cimarusti Non Executive Director
Mr. Humayun Dhanrajgir Ind. Non-Executive Director
Mrs. Bharati Rao Ind. Non-Executive Director
Dr. Nirmala Murthy Ind. Non-Executive Director
Mr. Parampally Vasudeva Maiya Ind. Non-Executive Director
Mr. Homi Rustum Khusrokhan Ind. Non-Executive Director
Mr. Prasad Raghava Menon Ind. Non-Executive Director

Neuland Laboratories Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Neuland Laboratories Corporate Action

Date Purpose Remarks
2023-11-07 Quarterly Results
2023-08-03 Quarterly Results
2023-05-11 Audited Results & Final Dividend
2023-02-13 Quarterly Results
2022-11-10 Quarterly Results
Date Purpose Remarks
2022-07-15 FINAL Rs.5.00 per share(50%)Final Dividend

Neuland Laboratories MF Shareholding

Name Amount(cr)
Quant Small Cap Fund Growth 9,521
WhiteOak Capital Flexi Cap Fund Regular Growth 2,375
Motilal Oswal Nifty Microcap 250 Index Fund Regular Growth 461
WhiteOak Capital Multi Cap Fund Regular Growth 459
WhiteOak Capital ELSS Tax Saver Fund Regular Growth 92

Neuland Laboratories FAQs

What is Share Price of Neuland Laboratories ?

Neuland Laboratories share price is ₹5,126 As on 06 December, 2023 | 03:10

What is the Market Cap of Neuland Laboratories ?

The Market Cap of Neuland Laboratories is ₹6577.5 Cr As on 06 December, 2023 | 03:10

What is the P/E ratio of Neuland Laboratories ?

The P/E ratio of Neuland Laboratories is 24.7 As on 06 December, 2023 | 03:10

What is the PB ratio of Neuland Laboratories ?

The PB ratio of Neuland Laboratories is 6.7 As on 06 December, 2023 | 03:10

Q2FY23